nialamide has been researched along with Adenocarcinoma in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tutton, PJ | 1 |
| Barkla, DH | 1 |
| Tatsuta, M | 1 |
| Iishi, H | 1 |
| Baba, M | 1 |
| Taniguchi, H | 1 |
2 other studies available for nialamide and Adenocarcinoma
| Article | Year |
|---|---|
A comparison of cell proliferation in normal and neoplastic intestinal epithelia following either biogenic amine depletion or monoamine oxidase inhibition.
Topics: Adenocarcinoma; Animals; Biogenic Amines; Cell Division; Colon; Colonic Neoplasms; Dimethylhydrazine | 1976 |
Promotion by nialamide of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Gastric Fundus; Gastric Mucosa; Gastrins; Male; Methylnitronitrosoguanidine | 1989 |